• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FERRING EUFLEXXA; INJECTION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FERRING EUFLEXXA; INJECTION Back to Search Results
Device Problem Overheating of Device (1437)
Patient Problem Sweating (2444)
Event Date 01/19/2016
Event Type  Injury  
Event Description
After my 2nd and 3rd euflexxa injections (they are given in a series of 3 injections, 1 week apart), within a half-hour of the injection, i became severely overheated and sweating all over my body for a couple of hours.About an hour or so after the injection, my heart began to race excessively and continue to do so for several hours thereafter.After about 16 hours or so, these symptoms completely resolved themselves.Dates of use: (b)(6) 2016.Reason for use: osteoarthritis of the knee.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EUFLEXXA
Type of Device
INJECTION
Manufacturer (Section D)
FERRING
MDR Report Key5393994
MDR Text Key36972471
Report NumberMW5059645
Device Sequence Number1
Product Code MOZ
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 01/20/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Initial Date Manufacturer Received Not provided
Initial Date FDA Received01/20/2016
Type of Device Usage N
Patient Sequence Number1
Patient Age63 YR
Patient Weight111
-
-